CA
PRTA icon

CoreCap Advisors’s Prothena Corp PRTA Stock Holding History

CoreCap Advisors’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$92 Hold
11
– – ﹤0.01% 3057
2026
Q2 		$108 Sell
11
-12
-52% -$118 ﹤0.01% 3069
2026
Q1 		$224 Hold
23
– – ﹤0.01% 2747
2025
Q4 		$220 Hold
23
– – ﹤0.01% 2805
2025
Q3 		$224 Hold
23
– – ﹤0.01% 2662
2025
Q2 		$140 Hold
23
– – ﹤0.01% 2659
2025
Q1 		$285 Hold
23
– – ﹤0.01% 2826
2024
Q4 		$319 Hold
23
– – ﹤0.01% 2618
2024
Q3 		$385 Hold
23
– – ﹤0.01% 2400
2024
Q2 		$475 Hold
23
– – ﹤0.01% 1454
2024
Q1 		$570 Buy
+23
New +$684 ﹤0.01% 2314
2022
Q4 		$1.39K Buy
+23
New +$1.35K ﹤0.01% 2005
2022
Q3 		– Sell
-11
Closed – – 1673
2022
Q2 		$0 Buy
+11
New +$322 ﹤0.01% 2240
2022
Q1 		– Sell
-11
Closed -$1K – 1677
2021
Q4 		$1K Buy
+11
New +$610 ﹤0.01% 2208

Other funds holding PRTA

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

CoreCap Advisors's PRTA Position: Q3 2026 in Review

CoreCap Advisors held its Prothena Corp (PRTA) position steady in Q3 2026 at 11 shares worth $92. The position accounts for ﹤0.01% of the portfolio, ranked #3057.

CoreCap Advisors first reported a position in PRTA in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.39K in Q4 2022. 4 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.

  • CoreCap Advisors held 11 shares of Prothena Corp worth $92 as of Q3 2026.
  • CoreCap Advisors left its Prothena Corp share count unchanged in Q3 2026.
  • Prothena Corp made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #3057 holding.
  • CoreCap Advisors first reported a position in Prothena Corp in Q4 2021 and has held it in 14 quarters since.
  • CoreCap Advisors's Prothena Corp position peaked at $1.39K in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.